# Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/eligibility-criteria-for-pediatric-patients-who-may-benefit-from-anti-sars-cov-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Marcello Lanari,Elisabetta Venturini,Luca Pierantoni,Giacomo Stera,Guido Castelli Gattinara,Susanna Esposito,Silvia Favilli,Emilio Franzonı,Eleonora Fusco,Paolo Lionetti,Claudio Maffeis,Gian Luigi Marseglia,Laura Massella,Fabio Midulla,A Zanobini,Marco Zecca,Alberto Villani,Annamaria Staiano,Luisa Galli,Other Collaborators,Francesco Blasi,Angelo Di Giorgio,Daniele Donà,Amelia Licari,Massimo Martinelli,Antonio Mastrangelo,Michele Miraglia del Giudice,Giangiacomo Nicolini,Fabrizio Pugliese,Pasquale Striano,Giuliana Valerio |
| Citations | 9 |
| DOI | 10.1186/s13052-021-01187-1 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://ijponline.biomedcentral.com/counter/pdf/10.1186/s13052-021-01187-1 |
| OpenAlex ID | https://openalex.org/W4206540596 |
| PMID | 35022088 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Eleonora Fusco](https://scholariq.org/researchers/eleonora-fusco/)

## Paper primary topic

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Paper topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.